Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening

Clin Cancer Res (2006) 12 (3): 751–758.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
  • Xiaoxu Fang
  • Shaokun Yu
  • Yingying Jiang
  • Yan Xiang
  • Kaihua Lu
Frontiers in Oncology (2022) 12
A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations
  • Hui Deng
  • Qian Lei
  • Chengdi Wang
  • Zhoufeng Wang
  • Hai Chen
  • Gang Wang
  • Na Yang
  • Dan Huang
  • Quanwei Yu
  • Mengling Yao
  • Xue Xiao
  • Guonian Zhu
  • Cheng Cheng
  • Yangqian Li
  • Feng Li
  • Panwen Tian
  • Weimin Li
Nature Communications (2022) 13 (1)
Integrating Cycled Enzymatic DNA Amplification and Surface-Enhanced Raman Scattering for Sensitive Detection of Circulating Tumor DNA
  • Xinxing Miao
  • Qianqian Fang
  • Xiang Xiao
  • Sidi Liu
  • Renfei Wu
  • Jun Yan
  • Baoqing Nie
  • Jian Liu
Frontiers in Molecular Biosciences (2021) 8
Innovative Tumor Tissue Dissection Tool for Molecular Oncology Diagnostics
  • Manana Javey
  • Christina Reinsch
  • Mirjam Feldkamp
  • Sandra Siemann
  • Anja Blüher
  • Corinna Woestmann
  • Lingling Cai
  • Ian Tran
  • Theresa May
  • Charles Havnar
  • Amy A. Lo
  • Bernd Hinzmann
  • Gabrielle Heilek
  • John F. Palma
The Journal of Molecular Diagnostics (2021) 23 (4): 399.
Perspectives for circulating tumor DNA in clinical management of colorectal cancer
  • Ichiro Takemasa
  • Atsushi Hamabe
  • Masayuki Ishii
International Journal of Clinical Oncology (2021) 26 (8): 1420.
Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer
  • Maik Haentschel
  • Michael Boeckeler
  • Ahmed Ehab
  • Robert Wagner
  • Werner Spengler
  • Volker Steger
  • Hans Boesmueller
  • Marius Horger
  • Richard A. Lewis
  • Falko Fend
  • Lothar Kanz
  • Irina Bonzheim
  • Juergen Hetzel
Lung Cancer (2020) 141: 56.
Somatic mutation detection efficiency in EGFR: a comparison between high resolution melting analysis and Sanger sequencing
  • Reenu Anne Joy
  • Sukrishna Kamalasanan Thelakkattusserry
  • Narendranath Vikkath
  • Renjitha Bhaskaran
  • Sajitha Krishnan
  • Damodaran Vasudevan
  • Prasanth S. Ariyannur
BMC Cancer (2020) 20 (1)
Conventional transbronchial needle aspiration is promising for identifying EGFR mutations in lung adenocarcinoma
  • Li‐Han Hsu
  • Jen‐Sheng Ko
  • Chia‐Chuan Liu
  • An‐Chen Feng
  • Nei‐Min Chu
Thoracic Cancer (2019) 10 (4): 856.
Fluorometric detection of EGFR exon 19 deletion mutation in lung cancer cells using graphene oxide
  • Dong-Min Kim
  • Dong Ho Kim
  • Woong Jung
  • Kye Young Lee
  • Dong-Eun Kim
The Analyst (2018) 143 (8): 1797.
Epidermal growth factor receptor (EGFR) in the era of Precision Medicine: The tale of a perfect example of targeted therapy. A review
  • Joseph Haddad
  • Silva Slika
  • Rami Mahfouz
Meta Gene (2017) 11: 157.
Prognostic value of rare and complex mutations in EGFR and serum levels of soluble EGFR and its ligands in non-small cell lung carcinoma patients
  • Seyyed Mortaza Haghgoo
  • Adnan Khosravi
  • Esmaeil Mortaz
  • Mihan Pourabdollah-Toutkaboni
  • Sharareh Seifi
  • Siamak Sabour
  • Abdolamir Allameh
Clinical Biochemistry (2017) 50 (6): 293.
EGFR , KRAS , BRAF and HER2 testing in metastatic lung adenocarcinoma: Value of testing on samples with poor specimen adequacy and analysis of discrepancies
  • Fabien Forest
  • Marie-Laure Stachowicz
  • François Casteillo
  • Georgia Karpathiou
  • Fabienne Gouzy-Grosjean
  • Colette Guilaubey
  • Michèle Cottier
  • Julie Beal
  • Alix Clemenson
  • Michel Péoc'h
Experimental and Molecular Pathology (2017) 103 (3): 306.
Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution
  • Kaidi Li
  • Maojun Yang
  • Naixin Liang
  • Shanqing Li
Oncology Reports (2017) 37 (3): 1347.
Sensitive genotyping of mutations in the EGFR gene from NSCLC patients using PCR-GoldMag lateral flow device
  • Xian-Ying Li
  • Chao Zhang
  • Qin-Lu Zhang
  • Juan-Li Zhu
  • Qian Liu
  • Ming-Wei Chen
  • Xue-Min Yang
  • Wen-Li Hui
  • Ya-Li Cui
Scientific Reports (2017) 7 (1)
Identification and Functional Characterization of EGFR V769M, a Novel Germline Variant Associated With Multiple Lung Adenocarcinomas
  • Matthew D. Hellmann
  • Takuo Hayashi
  • Boris Reva
  • Helena A. Yu
  • Gregory J. Riely
  • Prasad S. Adusumilli
  • William D. Travis
  • Olivia Wilkins
  • Nicole Bramletta
  • Raghu Chandramohan
  • Megan Harlan Fleischut
  • Mark G. Kris
  • Mark E. Robson
  • Maria E. Arcila
  • Paul K. Paik
  • Marc Ladanyi
JCO Precision Oncology (2017) (1): 1.
Sample types applied for molecular diagnosis of therapeutic management of advanced non-small cell lung cancer in the precision medicine
  • Yanxi Han
  • Jinming Li
Clinical Chemistry and Laboratory Medicine (CCLM) (2017) 55 (12)
The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016
  • Daniel S.W. Tan
  • Sue S. Yom
  • Ming S. Tsao
  • Harvey I. Pass
  • Karen Kelly
  • Nir Peled
  • Rex C. Yung
  • Ignacio I. Wistuba
  • Yasushi Yatabe
  • Michael Unger
  • Philip C. Mack
  • Murry W. Wynes
  • Tetsuya Mitsudomi
  • Walter Weder
  • David Yankelevitz
  • Roy S. Herbst
  • David R. Gandara
  • David P. Carbone
  • Paul A. Bunn
  • Tony S.K. Mok
  • Fred R. Hirsch
Journal of Thoracic Oncology (2016) 11 (7): 946.
A Novel Technique to Detect EGFR Mutations in Lung Cancer
  • Yuanbin Liu
  • Ting Lei
  • Zhiyu Liu
  • Yanbin Kuang
  • Jianxin Lyu
  • Qi Wang
International Journal of Molecular Sciences (2016) 17 (5): 792.
Detection and characterization of circulating cell free tumor DNA in cancer patients with malignant solid tumors. Liquid biopsy: a new tool in molecular pathology?
  • Tanja Hinrichsen
  • Juliane K. Dworniczak
  • Oliver Wachter
  • Bernd Dworniczak
  • Barbara Dockhorn-Dworniczak
LaboratoriumsMedizin (2016) 40 (5): 313.
Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer
  • Naiqing Xu
  • Wenfeng Fang
  • Libing Mu
  • Yanna Tang
  • Lei Gao
  • Shengxiang Ren
  • Dengfeng Cao
  • Lixin Zhou
  • Aiqun Zhang
  • Deruo Liu
  • Caicun Zhou
  • Kwok-Kin Wong
  • Lei Yu
  • Li Zhang
  • Liang Chen
Oncotarget (2016) 7 (4): 3884.
Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing
  • Kazuko Sakai
  • Junji Tsurutani
  • Takeharu Yamanaka
  • Azusa Yoneshige
  • Akihiko Ito
  • Yosuke Togashi
  • Marco A. De Velasco
  • Masato Terashima
  • Yoshihiko Fujita
  • Shuta Tomida
  • Takao Tamura
  • Kazuhiko Nakagawa
  • Kazuto Nishio
  • Ralf Krahe
PLOS ONE (2015) 10 (5): e0121891.
Predictive and Prognostic Markers in the Treatment of Metastatic Colorectal Cancer (mCRC)
  • Sebastian Stintzing
  • Stefan Stremitzer
  • Ana Sebio
  • Heinz-Josef Lenz
Hematology/Oncology Clinics of North America (2015) 29 (1): 43.
Identifying the determinants of response to MDM2 inhibition
  • Anne Y. Saiki
  • Sean Caenepeel
  • Elissa Cosgrove
  • Cheng Su
  • Michael Boedigheimer
  • Jonathan D. Oliner
Oncotarget (2015) 6 (10): 7701.
A rapid MZI-IDA sensor system for EGFR mutation testing in non-small cell lung cancer (NSCLC)
  • Qing Liu
  • Swee Yin Lim
  • Ross A. Soo
  • Mi Kyoung Park
  • Yong Shin
Biosensors and Bioelectronics (2015) 74: 865.
Carcinomes bronchiques non à petites cellules (CBNPC) métastatiques, mutés ou réarrangés : comment déterminer la cible ?
  • M. Beau-Faller
  • S. Renaud
  • N. Weingertner
  • V. Lindner
  • C. Emprou
  • P. Le Van Quyen
  • M. Legrain
  • A.-C. Voegeli
  • M.-P. Chenard
  • E. Pencreach
  • M.-P. Gaub
  • A. Schneider
  • É. Guerin
Revue des Maladies Respiratoires Actualités (2015) 7 (4): 476.
Emerging platforms using liquid biopsy to detectEGFRmutations in lung cancer
  • Chien-Chung Lin
  • Wei-Lun Huang
  • Fang Wei
  • Wu-Chou Su
  • David T Wong
Expert Review of Molecular Diagnostics (2015) 15 (11): 1427.
EGFR Analysis in Cytologic Samples of Lung Adenocarcinoma by Microdissection
  • Jeong Yeon Han
  • Hoon Taek Lee
  • Seo Young Oh
Korean Journal of Clinical Laboratory Science (2015) 47 (3): 125.
Delay of treatment change after objective progression on first‐line erlotinib in epidermal growth factor receptor‐mutant lung cancer
  • Peter C. Lo
  • Suzanne E. Dahlberg
  • Mizuki Nishino
  • Bruce E. Johnson
  • Lecia V. Sequist
  • David M. Jackman
  • Pasi A. Jänne
  • Geoffrey R. Oxnard
Cancer (2015) 121 (15): 2570.
Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition
  • Margaret Soucheray
  • Marzia Capelletti
  • Inés Pulido
  • Yanan Kuang
  • Cloud P. Paweletz
  • Jeffrey H. Becker
  • Eiki Kikuchi
  • Chunxiao Xu
  • Tarun B. Patel
  • Fatima Al-shahrour
  • Julián Carretero
  • Kwok-Kin Wong
  • Pasi A. Jänne
  • Geoffrey I. Shapiro
  • Takeshi Shimamura
Cancer Research (2015) 75 (20): 4372.
Rapid and label-free amplification and detection assay for genotyping of cancer biomarker
  • Yong Shin
  • Ross A Soo
  • Jaeyun Yoon
  • Agampodi Promoda Perera
  • Yong-Jin Yoon
  • Mi Kyoung Park
Biosensors and Bioelectronics (2015) 68: 107.
The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer
  • Wei-Lun Huang
  • Fang Wei
  • David T. Wong
  • Chien-Chung Lin
  • Wu-Chou Su
BioMed Research International (2015) 2015: 1.
Comprehensive detection of diverse exon 19 deletion mutations of EGFR in lung Cancer by a single probe set
  • Jin Ho Bae
  • Seong-Min Jo
  • Hak-Sung Kim
Biosensors and Bioelectronics (2015) 74: 849.
Molecular pathology in lung cancer: a guide to the techniques used in clinical practice
  • Kathy Walsh
  • William A Wallace
Histopathology (2014) 65 (6): 731.
Interference of Co-Amplified Nuclear Mitochondrial DNA Sequences on the Determination of Human mtDNA Heteroplasmy by Using the SURVEYOR Nuclease and the WAVE HS System
  • Hsiu-Chuan Yen
  • Shiue-Li Li
  • Wei-Chien Hsu
  • Petrus Tang
  • Feng Ling
PLoS ONE (2014) 9 (3): e92817.
Identification of Recurrent FGFR3–TACC3 Fusion Oncogenes from Lung Adenocarcinoma
  • Marzia Capelletti
  • Michael E. Dodge
  • Dalia Ercan
  • Peter S. Hammerman
  • Seung-Il Park
  • Jhingook Kim
  • Hidefumi Sasaki
  • David M. Jablons
  • Doron Lipson
  • Lauren Young
  • Phil J. Stephens
  • Vincent A. Miller
  • Neal I. Lindeman
  • Kiara J. Munir
  • William G. Richards
  • Pasi A. Jänne
Clinical Cancer Research (2014) 20 (24): 6551.
Liquid Biopsies: Genotyping Circulating Tumor DNA
  • Luis A. Diaz
  • Alberto Bardelli
Journal of Clinical Oncology (2014) 32 (6): 579.
Sample Features Associated with Success Rates in Population-Based EGFR Mutation Testing
  • Carolyn J. Shiau
  • Jesse P. Babwah
  • Gilda da Cunha Santos
  • Jenna R. Sykes
  • Scott L. Boerner
  • William R. Geddie
  • Natasha B. Leighl
  • Cuihong Wei
  • Suzanne Kamel-Reid
  • David M. Hwang
  • Ming-Sound Tsao
Journal of Thoracic Oncology (2014) 9 (7): 947.
Noninvasive Saliva-based EGFR Gene Mutation Detection in Patients with Lung Cancer
  • Fang Wei
  • Chien-Chung Lin
  • Aron Joon
  • Ziding Feng
  • Gabriel Troche
  • Maruja E. Lira
  • David Chia
  • Mao Mao
  • Chung-Liang Ho
  • Wu-Chou Su
  • David T. W. Wong
American Journal of Respiratory and Critical Care Medicine (2014) 190 (10): 1117.
Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
  • Hye-Ryoun Kim
  • Sung Yong Lee
  • Dae-Sung Hyun
  • Min Ki Lee
  • Hyun-Kyung Lee
  • Chang-Min Choi
  • Sei-Hoon Yang
  • Young-Chul Kim
  • Yong Chul Lee
  • Sun Young Kim
  • Seung Hun Jang
  • Jae Cheol Lee
  • Kye Young Lee
Journal of Experimental & Clinical Cancer Research (2013) 32 (1)
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients
  • Monic Roengvoraphoj
  • Gregory J. Tsongalis
  • Konstantin H. Dragnev
  • James R. Rigas
Cancer Treatment Reviews (2013) 39 (8): 839.
Common and Rare EGFR and KRAS Mutations in a Dutch Non-Small-Cell Lung Cancer Population and Their Clinical Outcome
  • Gerald S. M. A. Kerner
  • Ed Schuuring
  • Johanna Sietsma
  • Thijo J. N. Hiltermann
  • Remge M. Pieterman
  • Gerard P. J. de Leede
  • John W. G. van Putten
  • Jeroen Liesker
  • Tineke E. J. Renkema
  • Peter van Hengel
  • Inge Platteel
  • Wim Timens
  • Harry J. M. Groen
  • Surinder K. Batra
PLoS ONE (2013) 8 (7): e70346.
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
  • Neal I. Lindeman
  • Philip T. Cagle
  • Mary Beth Beasley
  • Dhananjay Arun Chitale
  • Sanja Dacic
  • Giuseppe Giaccone
  • Robert Brian Jenkins
  • David J. Kwiatkowski
  • Juan-Sebastian Saldivar
  • Jeremy Squire
  • Erik Thunnissen
  • Marc Ladanyi
Journal of Thoracic Oncology (2013) 8 (7): 823.
Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology
  • K. Perez
  • R. Walsh
  • K. Brilliant
  • L. Noble
  • E. Yakirevich
  • V. Breese
  • C. Jackson
  • D. Chatterjee
  • V. Pricolo
  • L. Roth
  • N. Shah
  • T. Cataldo
  • H. Safran
  • D. Hixson
  • P. Quesenberry
Experimental and Molecular Pathology (2013) 95 (1): 74.
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
  • Neal I. Lindeman
  • Philip T. Cagle
  • Mary Beth Beasley
  • Dhananjay Arun Chitale
  • Sanja Dacic
  • Giuseppe Giaccone
  • Robert Brian Jenkins
  • David J. Kwiatkowski
  • Juan-Sebastian Saldivar
  • Jeremy Squire
  • Erik Thunnissen
  • Marc Ladanyi
Archives of Pathology & Laboratory Medicine (2013) 137 (6): 828.
EGFRmutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
  • Gillian Ellison
  • Guanshan Zhu
  • Alexandros Moulis
  • Simon Dearden
  • Georgina Speake
  • Rose McCormack
Journal of Clinical Pathology (2013) 66 (2): 79.
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
  • Neal I. Lindeman
  • Philip T. Cagle
  • Mary Beth Beasley
  • Dhananjay Arun Chitale
  • Sanja Dacic
  • Giuseppe Giaccone
  • Robert Brian Jenkins
  • David J. Kwiatkowski
  • Juan-Sebastian Saldivar
  • Jeremy Squire
  • Erik Thunnissen
  • Marc Ladanyi
The Journal of Molecular Diagnostics (2013) 15 (4): 415.
Activating Germline R776H Mutation in the Epidermal Growth Factor Receptor Associated With Lung Cancer With Squamous Differentiation
  • Jan van Noesel
  • Ward H. van der Ven
  • Theo A.M. van Os
  • Peter W.A. Kunst
  • Jitske Weegenaar
  • Roy J.A. Reinten
  • Rama K. Kancha
  • Justus Duyster
  • Carel J.M. van Noesel
Journal of Clinical Oncology (2013) 31 (10): e161.
Immunostaining with EGFR mutation–specific antibodies: a reliable screening method for lung adenocarcinomas harboring EGFR mutation in biopsy and resection samples
  • Xiangshan Fan
  • Biao Liu
  • Haodong Xu
  • Bo Yu
  • Shanshan Shi
  • Jin Zhang
  • Xuan Wang
  • Jiandong Wang
  • Zhenfeng Lu
  • Henghui Ma
  • Xiaojun Zhou
Human Pathology (2013) 44 (8): 1499.
Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancer
  • Jong-Mu Sun
  • Sanjay Rampal
  • Genehee Lee
  • Jeeyun Lee
  • Yoon-La Choi
  • Bhash Parasuraman
  • Eliseo Guallar
  • Juhee Cho
  • Young Mog Shim
Lung Cancer (2013) 80 (2): 191.
Screening Human Genes for Small Alterations Performing an Enzymatic Cleavage Mismatched Analysis (ECMA) Protocol
  • Nikolaos Vogiatzakis
  • Kyriaki Kekou
  • Christalena Sophocleous
  • Sophia Kitsiou
  • Ariadni Mavrou
  • Chrisa Bakoula
  • Emmanouel Kanavakis
Molecular Biotechnology (2013) 55 (1): 1.
  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept